Parallel Session P12 - The international dimension of dementia
Detailed Programme and abstracts
Saturday, 2 October – 11.00-12.00 (Green Room)
P12.1. In Dementia Care – Is Australia the Lucky Country?
Frank J Schaper, Chief Executive Officer, Alzheimer's Australia WA
In 2005, Australia became the first country in the world to declare dementia, a national health priority. It followed the launch in 2003 of a report of the prevalence of dementia in Australia both at that time and into the future. The same report estimated the cost of dementia to the Australian community to be $6.9 billion.
Government response was swift and within two years, budget allocations were made for research, education, information and care and these were projected into the government’s forward estimates. There was also bi-partisan support and so all seemed secure for those that live with dementia on a daily basis – but was it?
This presentation will look at the ‘dementia initiative in Australia today. Is it still setting the pace and will it continue to challenge the rest of the world?
P12.2. Global Impact of Dementia
Marc Wortmann, Alzheimer’s Disease International, 64 Great Suffolk Street, London SE1 0BL, United Kingdom, firstname.lastname@example.org
On 21 September 2009 (World Alzheimer’s Day) Alzheimer’s Disease International (ADI), the international federation of 73 national Alzheimer organizations, released the World Alzheimer’s Report to raise awareness for the disease that will have a dramatic impact on individuals and healthcare systems globally. The report contains an overview of the global prevalence data and policy recommendations. A previous study was published in 2005 in Lancet ( Ferri et al. “World prevalence of dementia: a Delphi consensus study.” Lancet . Vol. 366, December 17/24/31, 2005). On 21 September 2010 a second report will be launched and this focuses on the economic impact of the disease.
The study is a meta-analysis of 167 prevalence studies from around the world by the 10/66 Dementia Research Group that is related to ADI. Inclusion criteria were: Population-based studies of the prevalence of dementia among people aged 60 years and over (according to DSM-IV or ICD-10 or similar criteria), for which the field work started on or after 1 January 1980. Excluded were, among others, studies on dementia subtypes only.
More than 35 million people worldwide will have dementia in 2010. This is a 10 percent increase over previous global dementia prevalence reported in the Lancet study. Dementia prevalence will nearly double every 20 years, to 65.7 million in 2030 and 115.4 million in 2050.
The increases were driven primarily by new data from low and middle-income countries. In addition, proportionate increases over the next 20 years in the number of people with dementia will be much steeper in low and middle compared with high-income countries.
The report also shows dementia is the leading cause of dependency and disability among older people.
The 2010 report will give the number of the global cost of the disease and this will be available by the time of the conference
Conclusions: The rapid growth in numbers should urge governments and the World Health Organization to declare dementia a health priority and develop strategies to support services for people with dementia and their families. More research needs to be funded and conducted into the causes of Alzheimer’s disease and other dementias, pharmacological and psychosocial treatments, the prevalence and impact of dementia, and the prevention of dementia.
P12.3. An Innovative Inpatient Rehabilitation Ward for Persons with Dementia in a Community Hospital in Singapore
Siew Li Cheung1, Kelvin Koh2, Boon Yeow Tan3, Christina Choy4, Isabella Liang5
1 St Luke’s Hospital, Singapore, Email : email@example.com
2 St Luke’s Hospital, Singapore, Email : firstname.lastname@example.org
3 St Luke’s Hospital, Singapore, Email : email@example.com
4 St Luke’s Hospital, Singapore, Email : christinachoy.slh.sg
5 St Luke’s Hospital, Singapore, Email : firstname.lastname@example.org
Persons with Dementia face higher physical, social and psychological risks and become more vulnerable as their illness progresses. They often face a higher risk of falling and consequent injuries due to decreased safety awareness and declining ability to orientate themselves to their environments. In addition, they face the risk of developing behavioural and psychological symptoms of dementia (BPSD) as the illness advances. These, together with their existing co-morbidities, necessitate a higher level of care that is often not available in an inpatient unit in an acute medical setting.
In Singapore, there are no inpatient rehabilitation units for Persons with Dementia in any acute medical settings. To address this gap, St Luke’s Hospital, a 185 bedded community hospital, created the first inpatient rehabilitation unit for Persons with Dementia in Singapore in 2006. The dementia care unit was built to respond to the increased needs of Persons with Dementia admitted for rehabilitation care and to better manage the specific needs of Persons with Dementia with BPSD through its systemised programme of care and innovative non-pharmacological interventions.
It was a pilot project with one ward converted and renovated to accommodate 16 female patients. The building of a safe therapeutic physical environment; a clearly defined admission criteria and comprehensive inter-disciplinary assessment process; regular reviews at multidisciplinary meetings and behavioural management team meetings; specifically tailored therapeutic and rehab programmes; use of non-pharmacological interventions and the development of a culturally relevant resource handbook to educate and prepare caregivers are some innovative elements of this ward.
With anticipated increased prevalence of dementia amongst older adults in Singapore, such a model of inpatient rehabilitation unit in other medical settings would address the rehabilitation needs of Persons with Dementia and allow them to remain in the community for as long as possible.
P12.4. Arts Engagement Programs for People with Dementia and their Caregivers
Amir Parsa, Laurel Humble
1 Amir Parsa – The Museum of Modern Art, USA, Amir_Parsa@moma.org
2 Laurel Humble – The Museum of Modern Art, USA, Laurel_Humble@moma.org
Art programs provide a means for creative engagement for people with Alzheimer’s disease; looking at and discussing works of art can allow for self-expression, intellectual stimulation, and social interaction. These phenomena can take place in a number of venues, including cultural institutions, care facilities, and private homes. The Museum of Modern Art in New York serves individuals with Alzheimer’s disease through various programs, including a gallery program for individuals in the early stages of the disease and their family or professional caregivers, called Meet Me at MoMA, as well as visits to and from assisted-living facilities and adult day service centers. Further, The MoMA Alzheimer’s Project endeavors to assist other museums, care organizations, and individual caregivers in making art accessible to people with dementia.
In this session, educators from The Museum of Modern Art will discuss ways of engaging individuals in the early to middle stages of Alzheimer’s disease and their caregivers with art. We will review MoMA’s programs in art and dementia, highlighting the particular benefits of different forms of engagement that fall therein, including art-based discussion and art-making projects. From there we will discuss ways of translating these programs to group or one-on-one experiences, be they at museums or art galleries, care facilities, in public spaces or the home. MoMA staff will detail these program models and highlight strategic partnerships with organizations working in the fields of creativity, aging, and dementia care.
Finally, we will discuss some of the potential benefits of engaging with art for individuals with Alzheimer’s disease and their caregivers. As part of The MoMA Alzheimer’s Project, funded by MetLife Foundation, the Museum contracted with the New York University School of Medicine to conduct an evidence-based research study of our Meet Me at MoMA program. This evaluation sought to measure particular changes to quality of life for participants as well as identify key components of the Meet Me at MoMA program that had the most significant impact on participants. Quality-of-life outcomes included elevation in mood for both participants. Additionally, participants with dementia reported elevation in self-esteem, while caregivers reported fewer emotional problems and a greater sense of social support as a result of participating in the Meet Me at MoMA program.
Last Updated: mercredi 03 novembre 2010